has-sante.fr/portail/upload/docs/application/pdf/2009- 02/synthese_inr_1437.pdf 3 ANSM. Bon usage des médicaments antivitamine K (AVK) juillet 2012 Available from, 2014. ,
Effet Indésirables des Médicaments : Incidence et Risque sur les hospitalisations liées à un effet indésirable médicamenteux, Coordination CRPV de Bordeaux, 2007. ,
Enquête sur les conditions de réalisation des prélèvements d'INR à domicile-pile ou face ?, Available fromnumero_etudian t=&numero_resume=318 Site certifié en partenariat avec la Haute Autorité de Santé (HAS), pp.4-9, 2011. ,
Aging and Warfarin Therapy, Annals of Internal Medicine, vol.117, issue.10, pp.878-887, 1992. ,
DOI : 10.7326/0003-4819-117-10-878
Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy, Clin Chem, vol.51, issue.3, pp.561-569, 2005. ,
situations à risque et accidents hémorragiques Available from : http://www.has-sante ,
Applicability of a compact PT-INR measuring device CoaguChek XS to perioperative management, Tokai J ,
The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients, Thrombosis Research, vol.130, issue.1, pp.110-114 ,
DOI : 10.1016/j.thromres.2011.08.027
Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic, Blood Coagulation & Fibrinolysis, vol.23, issue.2, pp.172-176, 2012. ,
DOI : 10.1097/MBC.0b013e32835029bf
Results of the performance verification of the CoaguChek XS system, of the performance verification of the CoaguChek XS system, pp.381-390, 2008. ,
DOI : 10.1016/j.thromres.2008.04.021
Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation, International Journal of Cardiology, vol.99, issue.1, pp.37-45, 2005. ,
DOI : 10.1016/j.ijcard.2003.11.008
Selfmonitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet, Feb, vol.4367, issue.9508, pp.404-415, 2006. ,
Automesure de l'INR : pour quels patientsAVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study, Presse Med. J Gen Intern Med, vol.3723, issue.9, pp.1441-1447, 2008. ,
Structuration d'un programme d'éducation thérapeutique du patient dans le champ des maladies chroniques Avalaible from, 2007. ,
Exp??rience d???un centre de suivi et de conseil des traitements anticoagulants oraux en m??decine de ville??: r??sultats ?? cinq ans, La Revue de M??decine Interne, vol.30, issue.7, pp.567-72, 2009. ,
DOI : 10.1016/j.revmed.2009.02.004
Les cliniques d'anticoagulants, Sang Thrombose Vaisseaux, vol.15, issue.6, pp.288-90, 2003. ,
Comparaison de??deux??m??thodes de??gestion d'un traitement antivitamine K: clinique des??anticoagulants (CAC) versus suivi conventionnel: ??tude randomis??e de??1005 patients, Journal des Maladies Vasculaires, vol.32, p.59, 2007. ,
DOI : 10.1016/j.jmv.2007.06.049
AnaStats Tours Available from : www.anastats.fr/stats/Documents/Conferences/Petits%20echantillons ,
The effect of time and temperature variables on routine coagulation tests, Blood Coagulation & Fibrinolysis, vol.9, issue.6, pp.463-70, 1998. ,
DOI : 10.1097/00001721-199809000-00002
Mid-term results of self-testing of the international normalized ratio in adults with a mechanical heart valve, Thrombosis Research, vol.133, issue.2, pp.149-53, 2014. ,
DOI : 10.1016/j.thromres.2013.09.013
Fibrillation auriculaire non valvulaire Quelle place pour les anticoagulants oraux non antivitamine K : apixaban (Eliquis®), dabigatran (Pradaxa®) et rivaroxaban (Xarelto®). septembre 2013 Available from ,
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial, The Lancet, vol.376, issue.9745, pp.975-83, 2010. ,
DOI : 10.1016/S0140-6736(10)61194-4
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.10, pp.883-91, 2011. ,
DOI : 10.1056/NEJMoa1009638
URL : https://hal.archives-ouvertes.fr/hal-01038111